Enterobacter ludwigii is Gram-negative, indicating a thin peptidoglycan layer in its cell wall. In Gram staining, it does not retain the purple stain.
The bacterium has a rod-shaped morphology featuring a cylindrical or elongated shape with rounded ends.
Enterobacter ludwigii is motile, employing one or more flagella for movement. Flagella are long, whip-like appendages protruding from the cell surface.
The bacterium is capable of producing exopolysaccharides (EPS), complex carbohydrates that can form a slimy layer around the cell or contribute to biofilm formation. EPS serves various functions, including adhesion to surfaces, protection against environmental stress, and evasion of the host immune system.
Enterobacter ludwigii produces enzymes that can degrade substrates like the polysaccharide xylan, which is present in plant cell walls. These enzymes contribute to the bacterium’s ability to utilize different carbon and energy sources and colonize diverse hosts and environments.
The antigenic types of Enterobacter ludwigii need to be better studied, but some information can be inferred from the related species of the ECC. The ECC species share a common O antigen, which is a polysaccharide component of the lipopolysaccharide (LPS) layer on the outer membrane of Gram-negative bacteria.
Repeating units make up the O antigen of four sugars: N-acetylglucosamine, galactose, rhamnose, and glucuronic acid4. However, the ECC species differ in their K antigens, which are capsular polysaccharides that surround the LPS layer and protect the bacteria from phagocytosis and complement-mediated killing.
The K antigens are classified into serotypes based on their antigenic properties and chemical structures4. For example, Enterobacter cloacae has at least 36 K serotypes, while Enterobacter hormaechei has 15 K serotypes4. The K serotypes of Enterobacter ludwigii are unknown, but they may be like those of other ECC species.
Enterobacter ludwigii is a Gram-negative bacterium that belongs to the Enterobacter cloacae complex, which comprises several animals that can infect humans with opportunistic illnesses and animals. The pathogenesis of E. ludwigii is not well understood, but some possible factors are:
E. ludwigii can form biofilms on various surfaces, such as urinary catheters, central venous catheters, and orthopedic implants. A self-produced matrix shields communities of microorganisms known as biofilms and is more resistant to antibiotics and host defenses.
E. ludwigii can secrete a bacterium onto plant seeds during insect feeding, which may facilitate its transmission and persistence in the environment.
E. ludwigii can harbor several antimicrobial resistance genes, such as blaCTX-M-15, blaTEM-1, blaSHV-12, aac(6′)-Ib-cr, and qnrB1, which confer resistance to beta-lactams, aminoglycosides, and quinolones.
E. ludwigii may have an extended cyclic di-GMP signaling network, which is involved in regulating bacterial motility, adhesion, and virulence.
The host defenses of Enterobacter ludwigii are not well understood, but some studies have suggested that this bacterium can evade or suppress the insect’s immune system by various mechanisms. For example, Enterobacter ludwigii can produce siderophores, which are molecules that bind and transport iron, an essential nutrient for bacterial growth and survival. By sequestering iron from the insect’s hemolymph, Enterobacter ludwigii can limit the availability of iron for the insect’s immune cells and thus reduce their antimicrobial activity.
Additionally, Enterobacter ludwigii can also interfere with the insect’s humoral antibacterial response, which is mediated by the generation of oxygen species that respond to nitric oxide (NO). Enterobacter ludwigii can degrade ROS and NO by expressing catalase and nitric oxide reductase, respectively, and thus protect itself from the oxidative and nitrosative stress induced by the insect’s immune system.
Furthermore, Enterobacter ludwigii can also manipulate the insect’s immune signaling pathways by producing molecules that mimic or inhibit the insect’s immune regulators, such as peptidoglycan recognition proteins (PGRPs) and Toll-like receptors (TLRs). By doing so, Enterobacter ludwigii can modulate the expression of immune-related genes and proteins in the insect and thus alter the insect’s immune response.
Enterobacter ludwigii is a rare cause of human infections, and only a few cases have been reported in the literature. One of them was a case of bloodstream infection due to Enterobacter ludwigii, which was associated with a massive aggregation of bacteria on the surface of a central venous catheter (CVC). The patient was a 57-year-old man who had a history of spondylodiscitis and endocarditis. He developed signs of infection, such as fever, chills, and hypotension, and the CVC was removed 11 days after placement. Standard and molecular methods identified the bacteria as Enterobacter ludwigii, a species that is closely related to Enterobacter cloacae complex (ECC).
The clinical manifestations of Enterobacter ludwigii infection may differ according to the location and intensity of the infection, as well as the underlying conditions and immune status of the patient. In general, Enterobacter infections can cause symptoms such as fever, pneumonia, cough, shortness of breath, urinary tract infection, painful urination, wound infection, and sepsis1. Some Enterobacter species, especially those belonging to the ECC, can also produce enzymes called β-lactamases, which can make them resistant to many antibiotics. Therefore, it is essential to identify the exact species and susceptibility profile of the bacteria causing the infection and to choose the appropriate antibiotic therapy accordingly.
The diagnosis of Enterobacter ludwigii infection can be done by using different laboratory methods, such as:
Blood cultures: This is a test that includes drawing blood from the patient in sample form and growing it in a particular medium to see if any bacteria are present. If Enterobacter ludwigii is detected, it can be further identified by using biochemical and molecular tests.
Gram stain: This is a test that involves staining a sample of bacteria with a dye that can differentiate between Gram-positive and Gram-negative bacteria. Enterobacter ludwigii is a Gram-negative bacterium, which means it will appear pink or red under a microscope.
Other tests: Depending on the site and severity of the infection, other tests may be needed, such as the complete metabolic panel and the complete blood count (CBC), urinalysis with culture, and imaging studies.
To prevent infections caused by Enterobacter ludwigii, you can follow some general hygiene and infection control measures, such as:
Wash your hands frequently with soap and drink, particularly in the morning and after eating, and using the loo, touching your face, or handling wounds.
Don’t share personal things like razors and towels, toothbrushes, or cosmetics with others.
Keep your wounds clean and covered with sterile dressings and change them regularly. Seek medical attention if your wound shows symptoms of infection, including fever, pus, redness, swelling, and discomfort.
Make sure your immunizations are current, especially those that protect against bacterial infections, such as tetanus, diphtheria, and pertussis.
Bloodstream infection due to Enterobacter ludwigii, correlating with massive aggregation on the surface of a central venous catheter | Infection (springer.com)
Enterobacter spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance. – Abstract – Europe PMC
Enterobacter ludwigii is Gram-negative, indicating a thin peptidoglycan layer in its cell wall. In Gram staining, it does not retain the purple stain.
The bacterium has a rod-shaped morphology featuring a cylindrical or elongated shape with rounded ends.
Enterobacter ludwigii is motile, employing one or more flagella for movement. Flagella are long, whip-like appendages protruding from the cell surface.
The bacterium is capable of producing exopolysaccharides (EPS), complex carbohydrates that can form a slimy layer around the cell or contribute to biofilm formation. EPS serves various functions, including adhesion to surfaces, protection against environmental stress, and evasion of the host immune system.
Enterobacter ludwigii produces enzymes that can degrade substrates like the polysaccharide xylan, which is present in plant cell walls. These enzymes contribute to the bacterium’s ability to utilize different carbon and energy sources and colonize diverse hosts and environments.
The antigenic types of Enterobacter ludwigii need to be better studied, but some information can be inferred from the related species of the ECC. The ECC species share a common O antigen, which is a polysaccharide component of the lipopolysaccharide (LPS) layer on the outer membrane of Gram-negative bacteria.
Repeating units make up the O antigen of four sugars: N-acetylglucosamine, galactose, rhamnose, and glucuronic acid4. However, the ECC species differ in their K antigens, which are capsular polysaccharides that surround the LPS layer and protect the bacteria from phagocytosis and complement-mediated killing.
The K antigens are classified into serotypes based on their antigenic properties and chemical structures4. For example, Enterobacter cloacae has at least 36 K serotypes, while Enterobacter hormaechei has 15 K serotypes4. The K serotypes of Enterobacter ludwigii are unknown, but they may be like those of other ECC species.
Enterobacter ludwigii is a Gram-negative bacterium that belongs to the Enterobacter cloacae complex, which comprises several animals that can infect humans with opportunistic illnesses and animals. The pathogenesis of E. ludwigii is not well understood, but some possible factors are:
E. ludwigii can form biofilms on various surfaces, such as urinary catheters, central venous catheters, and orthopedic implants. A self-produced matrix shields communities of microorganisms known as biofilms and is more resistant to antibiotics and host defenses.
E. ludwigii can secrete a bacterium onto plant seeds during insect feeding, which may facilitate its transmission and persistence in the environment.
E. ludwigii can harbor several antimicrobial resistance genes, such as blaCTX-M-15, blaTEM-1, blaSHV-12, aac(6′)-Ib-cr, and qnrB1, which confer resistance to beta-lactams, aminoglycosides, and quinolones.
E. ludwigii may have an extended cyclic di-GMP signaling network, which is involved in regulating bacterial motility, adhesion, and virulence.
The host defenses of Enterobacter ludwigii are not well understood, but some studies have suggested that this bacterium can evade or suppress the insect’s immune system by various mechanisms. For example, Enterobacter ludwigii can produce siderophores, which are molecules that bind and transport iron, an essential nutrient for bacterial growth and survival. By sequestering iron from the insect’s hemolymph, Enterobacter ludwigii can limit the availability of iron for the insect’s immune cells and thus reduce their antimicrobial activity.
Additionally, Enterobacter ludwigii can also interfere with the insect’s humoral antibacterial response, which is mediated by the generation of oxygen species that respond to nitric oxide (NO). Enterobacter ludwigii can degrade ROS and NO by expressing catalase and nitric oxide reductase, respectively, and thus protect itself from the oxidative and nitrosative stress induced by the insect’s immune system.
Furthermore, Enterobacter ludwigii can also manipulate the insect’s immune signaling pathways by producing molecules that mimic or inhibit the insect’s immune regulators, such as peptidoglycan recognition proteins (PGRPs) and Toll-like receptors (TLRs). By doing so, Enterobacter ludwigii can modulate the expression of immune-related genes and proteins in the insect and thus alter the insect’s immune response.
Enterobacter ludwigii is a rare cause of human infections, and only a few cases have been reported in the literature. One of them was a case of bloodstream infection due to Enterobacter ludwigii, which was associated with a massive aggregation of bacteria on the surface of a central venous catheter (CVC). The patient was a 57-year-old man who had a history of spondylodiscitis and endocarditis. He developed signs of infection, such as fever, chills, and hypotension, and the CVC was removed 11 days after placement. Standard and molecular methods identified the bacteria as Enterobacter ludwigii, a species that is closely related to Enterobacter cloacae complex (ECC).
The clinical manifestations of Enterobacter ludwigii infection may differ according to the location and intensity of the infection, as well as the underlying conditions and immune status of the patient. In general, Enterobacter infections can cause symptoms such as fever, pneumonia, cough, shortness of breath, urinary tract infection, painful urination, wound infection, and sepsis1. Some Enterobacter species, especially those belonging to the ECC, can also produce enzymes called β-lactamases, which can make them resistant to many antibiotics. Therefore, it is essential to identify the exact species and susceptibility profile of the bacteria causing the infection and to choose the appropriate antibiotic therapy accordingly.
The diagnosis of Enterobacter ludwigii infection can be done by using different laboratory methods, such as:
Blood cultures: This is a test that includes drawing blood from the patient in sample form and growing it in a particular medium to see if any bacteria are present. If Enterobacter ludwigii is detected, it can be further identified by using biochemical and molecular tests.
Gram stain: This is a test that involves staining a sample of bacteria with a dye that can differentiate between Gram-positive and Gram-negative bacteria. Enterobacter ludwigii is a Gram-negative bacterium, which means it will appear pink or red under a microscope.
Other tests: Depending on the site and severity of the infection, other tests may be needed, such as the complete metabolic panel and the complete blood count (CBC), urinalysis with culture, and imaging studies.
To prevent infections caused by Enterobacter ludwigii, you can follow some general hygiene and infection control measures, such as:
Wash your hands frequently with soap and drink, particularly in the morning and after eating, and using the loo, touching your face, or handling wounds.
Don’t share personal things like razors and towels, toothbrushes, or cosmetics with others.
Keep your wounds clean and covered with sterile dressings and change them regularly. Seek medical attention if your wound shows symptoms of infection, including fever, pus, redness, swelling, and discomfort.
Make sure your immunizations are current, especially those that protect against bacterial infections, such as tetanus, diphtheria, and pertussis.
Bloodstream infection due to Enterobacter ludwigii, correlating with massive aggregation on the surface of a central venous catheter | Infection (springer.com)
Enterobacter spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance. – Abstract – Europe PMC
Enterobacter ludwigii is Gram-negative, indicating a thin peptidoglycan layer in its cell wall. In Gram staining, it does not retain the purple stain.
The bacterium has a rod-shaped morphology featuring a cylindrical or elongated shape with rounded ends.
Enterobacter ludwigii is motile, employing one or more flagella for movement. Flagella are long, whip-like appendages protruding from the cell surface.
The bacterium is capable of producing exopolysaccharides (EPS), complex carbohydrates that can form a slimy layer around the cell or contribute to biofilm formation. EPS serves various functions, including adhesion to surfaces, protection against environmental stress, and evasion of the host immune system.
Enterobacter ludwigii produces enzymes that can degrade substrates like the polysaccharide xylan, which is present in plant cell walls. These enzymes contribute to the bacterium’s ability to utilize different carbon and energy sources and colonize diverse hosts and environments.
The antigenic types of Enterobacter ludwigii need to be better studied, but some information can be inferred from the related species of the ECC. The ECC species share a common O antigen, which is a polysaccharide component of the lipopolysaccharide (LPS) layer on the outer membrane of Gram-negative bacteria.
Repeating units make up the O antigen of four sugars: N-acetylglucosamine, galactose, rhamnose, and glucuronic acid4. However, the ECC species differ in their K antigens, which are capsular polysaccharides that surround the LPS layer and protect the bacteria from phagocytosis and complement-mediated killing.
The K antigens are classified into serotypes based on their antigenic properties and chemical structures4. For example, Enterobacter cloacae has at least 36 K serotypes, while Enterobacter hormaechei has 15 K serotypes4. The K serotypes of Enterobacter ludwigii are unknown, but they may be like those of other ECC species.
Enterobacter ludwigii is a Gram-negative bacterium that belongs to the Enterobacter cloacae complex, which comprises several animals that can infect humans with opportunistic illnesses and animals. The pathogenesis of E. ludwigii is not well understood, but some possible factors are:
E. ludwigii can form biofilms on various surfaces, such as urinary catheters, central venous catheters, and orthopedic implants. A self-produced matrix shields communities of microorganisms known as biofilms and is more resistant to antibiotics and host defenses.
E. ludwigii can secrete a bacterium onto plant seeds during insect feeding, which may facilitate its transmission and persistence in the environment.
E. ludwigii can harbor several antimicrobial resistance genes, such as blaCTX-M-15, blaTEM-1, blaSHV-12, aac(6′)-Ib-cr, and qnrB1, which confer resistance to beta-lactams, aminoglycosides, and quinolones.
E. ludwigii may have an extended cyclic di-GMP signaling network, which is involved in regulating bacterial motility, adhesion, and virulence.
The host defenses of Enterobacter ludwigii are not well understood, but some studies have suggested that this bacterium can evade or suppress the insect’s immune system by various mechanisms. For example, Enterobacter ludwigii can produce siderophores, which are molecules that bind and transport iron, an essential nutrient for bacterial growth and survival. By sequestering iron from the insect’s hemolymph, Enterobacter ludwigii can limit the availability of iron for the insect’s immune cells and thus reduce their antimicrobial activity.
Additionally, Enterobacter ludwigii can also interfere with the insect’s humoral antibacterial response, which is mediated by the generation of oxygen species that respond to nitric oxide (NO). Enterobacter ludwigii can degrade ROS and NO by expressing catalase and nitric oxide reductase, respectively, and thus protect itself from the oxidative and nitrosative stress induced by the insect’s immune system.
Furthermore, Enterobacter ludwigii can also manipulate the insect’s immune signaling pathways by producing molecules that mimic or inhibit the insect’s immune regulators, such as peptidoglycan recognition proteins (PGRPs) and Toll-like receptors (TLRs). By doing so, Enterobacter ludwigii can modulate the expression of immune-related genes and proteins in the insect and thus alter the insect’s immune response.
Enterobacter ludwigii is a rare cause of human infections, and only a few cases have been reported in the literature. One of them was a case of bloodstream infection due to Enterobacter ludwigii, which was associated with a massive aggregation of bacteria on the surface of a central venous catheter (CVC). The patient was a 57-year-old man who had a history of spondylodiscitis and endocarditis. He developed signs of infection, such as fever, chills, and hypotension, and the CVC was removed 11 days after placement. Standard and molecular methods identified the bacteria as Enterobacter ludwigii, a species that is closely related to Enterobacter cloacae complex (ECC).
The clinical manifestations of Enterobacter ludwigii infection may differ according to the location and intensity of the infection, as well as the underlying conditions and immune status of the patient. In general, Enterobacter infections can cause symptoms such as fever, pneumonia, cough, shortness of breath, urinary tract infection, painful urination, wound infection, and sepsis1. Some Enterobacter species, especially those belonging to the ECC, can also produce enzymes called β-lactamases, which can make them resistant to many antibiotics. Therefore, it is essential to identify the exact species and susceptibility profile of the bacteria causing the infection and to choose the appropriate antibiotic therapy accordingly.
The diagnosis of Enterobacter ludwigii infection can be done by using different laboratory methods, such as:
Blood cultures: This is a test that includes drawing blood from the patient in sample form and growing it in a particular medium to see if any bacteria are present. If Enterobacter ludwigii is detected, it can be further identified by using biochemical and molecular tests.
Gram stain: This is a test that involves staining a sample of bacteria with a dye that can differentiate between Gram-positive and Gram-negative bacteria. Enterobacter ludwigii is a Gram-negative bacterium, which means it will appear pink or red under a microscope.
Other tests: Depending on the site and severity of the infection, other tests may be needed, such as the complete metabolic panel and the complete blood count (CBC), urinalysis with culture, and imaging studies.
To prevent infections caused by Enterobacter ludwigii, you can follow some general hygiene and infection control measures, such as:
Wash your hands frequently with soap and drink, particularly in the morning and after eating, and using the loo, touching your face, or handling wounds.
Don’t share personal things like razors and towels, toothbrushes, or cosmetics with others.
Keep your wounds clean and covered with sterile dressings and change them regularly. Seek medical attention if your wound shows symptoms of infection, including fever, pus, redness, swelling, and discomfort.
Make sure your immunizations are current, especially those that protect against bacterial infections, such as tetanus, diphtheria, and pertussis.
Bloodstream infection due to Enterobacter ludwigii, correlating with massive aggregation on the surface of a central venous catheter | Infection (springer.com)
Enterobacter spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance. – Abstract – Europe PMC
Loading...
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
